Abstract

Mini Review

Interconnection and Communication between Bone Marrow - The Central Immune System - And the Central Nervous System

Volker Schirrmacher*

Published: 25 September, 2023 | Volume 7 - Issue 2 | Pages: 090-093

Bone marrow and the central nervous system are both protected by bone. The two systems are interconnected not only structurally but also functionally. In both systems specialized cells communicate through synapses. There exists a tridirectional communication within the neuroimmune network, including the hormonal system, the immune system, and the nervous system. Bone marrow is a priming site for T cell responses to blood-borne antigens including those from the central nervous system. In cases of auto (self) antigens, the responses lead to immune tolerance while in cases of neo (non-self) antigens, the responses lead to neoantigen-specific T cell activation, immune control, and finally to the generation of neoantigen-specific immunological memory. Bone marrow has an important function in the storage and maintenance of immunological memory. It is a multifunctional and very active cell-generating organ, constantly providing hematopoiesis and osteogenesis in finely-tuned homeostasis. Clinical perspectives include mesenchymal stem cell transplantation for tissue repair within the central nervous system.

Read Full Article HTML DOI: 10.29328/journal.jnnd.1001082 Cite this Article Read Full Article PDF

Keywords:

Synapse; Memory; Neuroimmune network; Immune surveillance; Neuropathologies

References

  1. Schirrmacher V. Bone marrow: The central immune system. 2023; 3:289-329. Doi.org/10.3390/immuno3030019.
  2. Wu K, Li R, Zhang Y, Liu Y, Wang M, Huang J, Zhu C, Zhang J, Yuan X, Liu Q. The discovery of a new type of innervation in lymphoid organs. Physiol Rep. 2023 Feb;11(4):e15604. doi: 10.14814/phy2.15604. PMID: 36823776; PMCID: PMC9950540.
  3. Nombela-Arrieta C, Manz MG. Quantification and three-dimensional microanatomical organization of the bone marrow. Blood Adv. 2017 Feb 14;1(6):407-416. doi: 10.1182/bloodadvances.2016003194. PMID: 29296956; PMCID: PMC5738992.
  4. Feuerer M, Beckhove P, Garbi N, Mahnke Y, Limmer A, Hommel M, Hämmerling GJ, Kyewski B, Hamann A, Umansky V, Schirrmacher V. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat Med. 2003 Sep;9(9):1151-7. doi: 10.1038/nm914. Epub 2003 Aug 10. PMID: 12910264.
  5. Milo I, Sapoznikov A, Kalchenko V, Tal O, Krauthgamer R, van Rooijen N, Dudziak D, Jung S, Shakhar G. Dynamic imaging reveals promiscuous crosspresentation of blood-borne antigens to naive CD8+ T cells in the bone marrow. Blood. 2013 Jul 11;122(2):193-208. doi: 10.1182/blood-2012-01-401265. Epub 2013 May 1. PMID: 23637125.
  6. Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Flavell RA. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med. 2001 Mar 19;193(6):741-54. doi: 10.1084/jem.193.6.741. PMID: 11257140; PMCID: PMC2193418.
  7. Abbas A, Lichtman A, Pillai S. Cellular and Molecular Immunology. 10th ed. Elsevier: Philadelphia, PA, USA. 2022.
  8. Møllgård K, Beinlich FRM, Kusk P, Miyakoshi LM, Delle C, Plá V, Hauglund NL, Esmail T, Rasmussen MK, Gomolka RS, Mori Y, Nedergaard M. A mesothelium divides the subarachnoid space into functional compartments. Science. 2023 Jan 6;379(6627):84-88. doi: 10.1126/science.adc8810. Epub 2023 Jan 5. PMID: 36603070.
  9. Mills WA 3rd, Coburn MA, Eyo UB. The emergence of the calvarial hematopoietic niche in health and disease. Immunol Rev. 2022 Oct;311(1):26-38. doi: 10.1111/imr.13120. Epub 2022 Jul 26. PMID: 35880587; PMCID: PMC9489662.
  10. Petry P, Oschwald A, Kierdorf K. Microglial tissue surveillance: The never-resting gardener in the developing and adult CNS. Eur J Immunol. 2023 Jul;53(7):e2250232. doi: 10.1002/eji.202250232. Epub 2023 May 5. PMID: 37042800.
  11. Arutyunov A, Klein RS. Microglia at the scene of the crime: what their transcriptomics reveal about brain health. Curr Opin Neurol. 2023 Jun 1;36(3):207-213. doi: 10.1097/WCO.0000000000001151. Epub 2023 Apr 18. PMID: 37078646.
  12. Dzyubenko E, Hermann DM. Role of glia and extracellular matrix in controlling neuroplasticity in the central nervous system. Semin Immunopathol. 2023 May;45(3):377-387. doi: 10.1007/s00281-023-00989-1. Epub 2023 Apr 13. PMID: 37052711; PMCID: PMC10279577.
  13. Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018 Oct;19(10):622-635. doi: 10.1038/s41583-018-0057-5. PMID: 30206328; PMCID: PMC7255106.
  14. de Ceglia R, Ledonne A, Litvin DG, Lind BL, Carriero G, Latagliata EC, Bindocci E, Di Castro MA, Savtchouk I, Vitali I, Ranjak A, Congiu M, Canonica T, Wisden W, Harris K, Mameli M, Mercuri N, Telley L, Volterra A. Specialized astrocytes mediate glutamatergic gliotransmission in the CNS. Nature. 2023 Sep 6. doi: 10.1038/s41586-023-06502-w. Epub ahead of print. PMID: 37674083.
  15. Barden MM, Omuro AM. Top advances of the year: Neuro-oncology. Cancer. 2023 May 15;129(10):1467-1472. doi: 10.1002/cncr.34711. Epub 2023 Feb 24. PMID: 36825454.
  16. Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rudà R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gørløv JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG). Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6. PMID: 27132696.
  17. Mahajan S, Schmidt MHH, Schumann U. The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens. Cancers (Basel). 2023 Mar 28;15(7):2024. doi: 10.3390/cancers15072024. PMID: 37046685; PMCID: PMC10093409.
  18. Bunse L, Bunse T, Krämer C, Chih YC, Platten M. Clinical and Translational Advances in Glioma Immunotherapy. Neurotherapeutics. 2022 Oct;19(6):1799-1817. doi: 10.1007/s13311-022-01313-9. Epub 2022 Oct 27. PMID: 36303101; PMCID: PMC9723056.
  19. Schirrmacher V, van Gool S, Stuecker W. Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy. Int J Mol Sci. 2022 Oct 27;23(21):13050. doi: 10.3390/ijms232113050. PMID: 36361831; PMCID: PMC9655431.
  20. Van Gool SW, Makalowski J, Bitar M, Van de Vliet P, Schirrmacher V, Stuecker W. Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients. Genes Immun. 2022 Dec;23(8):255-259. doi: 10.1038/s41435-022-00162-y. Epub 2022 Feb 16. PMID: 35173295; PMCID: PMC9758045.
  21. Van Gool SW, Makalowski J, Fiore S, Sprenger T, Prix L, Schirrmacher V, Stuecker W. Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged. Cancers (Basel). 2020 Dec 24;13(1):32. doi: 10.3390/cancers13010032. PMID: 33374196; PMCID: PMC7796083.
  22. Van de Vliet P, Sprenger T, Kampers LFC, Makalowski J, Schirrmacher V, Stücker W, Van Gool SW. The Application of Evidence-Based Medicine in Individualized Medicine. Biomedicines. 2023 Jun 23;11(7):1793. doi: 10.3390/biomedicines11071793. PMID: 37509433; PMCID: PMC10376974.
  23. Yoshimura A, Ohyagi M, Ito M. T cells in the brain inflammation. Adv Immunol. 2023;157:29-58. doi: 10.1016/bs.ai.2022.10.001. Epub 2022 Nov 24. PMID: 37061287.
  24. Eliseeva DD, Zakharova MN. Myelin Oligodendrocyte Glycoprotein as an Autoantigen in Inflammatory Demyelinating Diseases of the Central Nervous System. Biochemistry (Mosc). 2023 Apr;88(4):551-563. doi: 10.1134/S0006297923040107. PMID: 37080940.
  25. Maïer B, Tsai AS, Einhaus JF, Desilles JP, Ho-Tin-Noé B, Gory B, Sirota M, Leigh R, Lemmens R, Albers G, Olivot JM, Mazighi M, Gaudillière B. Neuroimaging is the new "spatial omic": multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke. Semin Immunopathol. 2023 Jan;45(1):125-143. doi: 10.1007/s00281-023-00984-6. Epub 2023 Feb 14. PMID: 36786929; PMCID: PMC10026385.
  26. Boyuklieva R, Pilicheva B. Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders. Biomedicines. 2022 Jul 14;10(7):1706. doi: 10.3390/biomedicines10071706. PMID: 35885011; PMCID: PMC9313014.
  27. Selles MC, Fortuna JTS, Cercato MC, Santos LE, Domett L, Bitencourt ALB, Carraro MF, Souza AS, Janickova H, Azevedo CV, Campos HC, de Souza JM, Alves-Leon S, Prado VF, Prado MAM, Epstein AL, Salvetti A, Longo BM, Arancio O, Klein WL, Sebollela A, De Felice FG, Jerusalinsky DA, Ferreira ST. AAV-mediated neuronal expression of an scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models. Mol Ther. 2023 Feb 1;31(2):409-419. doi: 10.1016/j.ymthe.2022.11.002. Epub 2022 Nov 11. PMID: 36369741; PMCID: PMC9931599.
  28. de Lucas ÁG, Lamminmäki U, López-Picón FR. ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience. Biomolecules. 2023 Jan 13;13(1):164. doi: 10.3390/biom13010164. PMID: 36671549; PMCID: PMC9855881.
  29. Torres Iglesias G, Fernández-Fournier M, Botella L, Piniella D, Laso-García F, Carmen Gómez-de Frutos M, Chamorro B, Puertas I, Tallón Barranco A, Fuentes B, Alonso de Leciñana M, Alonso-López E, Bravo SB, Eugenia Miranda-Carús M, Montero-Calle A, Barderas R, Díez-Tejedor E, Gutiérrez-Fernández M, Otero-Ortega L. Brain and immune system-derived extracellular vesicles mediate regulation of complement system, extracellular matrix remodeling, brain repair and antigen tolerance in Multiple sclerosis. Brain Behav Immun. 2023 Oct;113:44-55. doi: 10.1016/j.bbi.2023.06.025. Epub 2023 Jul 3. PMID: 37406976.
  30. Chen X, Xu CX, Liang H, Xi Z, Pan J, Yang Y, Sun Q, Yang G, Sun Y, Bian L. Bone marrow mesenchymal stem cells transplantation alleviates brain injury after intracerebral hemorrhage in mice through the Hippo signaling pathway. Aging (Albany NY). 2020 Apr 9;12(7):6306-6323. doi: 10.18632/aging.103025. Epub 2020 Apr 9. PMID: 32271159; PMCID: PMC7185092.
  31. Tfilin M, Gobshtis N, Fozailoff D, Fraifeld VE, Turgeman G. Polarized Anti-Inflammatory Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Improve Cognitive Function in Aged Mice. Int J Mol Sci. 2023 Feb 24;24(5):4490. doi: 10.3390/ijms24054490. PMID: 36901920; PMCID: PMC10003244.
  32. Hong CG, Chen ML, Duan R, Wang X, Pang ZL, Ge LT, Lu M, Xie H, Liu ZZ. Transplantation of Nasal Olfactory Mucosa Mesenchymal Stem Cells Benefits Alzheimer's Disease. Mol Neurobiol. 2022 Dec;59(12):7323-7336. doi: 10.1007/s12035-022-03044-6. Epub 2022 Sep 29. PMID: 36173534.
  33. Qu M, Xing F, Xing N. Mesenchymal stem cells for the treatment of cognitive impairment caused by neurological diseases. Biotechnol Lett. 2022 Aug;44(8):903-916. doi: 10.1007/s10529-022-03274-7. Epub 2022 Jul 9. PMID: 35809141.
  34. Nakano M, Kubota K, Kobayashi E, Chikenji TS, Saito Y, Konari N, Fujimiya M. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer's disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep. 2020 Jul 1;10(1):10772. doi: 10.1038/s41598-020-67460-1. PMID: 32612165; PMCID: PMC7330036.
  35. Vigo T, Voulgari-Kokota A, Errede M, Girolamo F, Ortolan J, Mariani MC, Ferrara G, Virgintino D, Buffo A, Kerlero de Rosbo N, Uccelli A. Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytes. Glia. 2021 May;69(5):1204-1215. doi: 10.1002/glia.23958. Epub 2020 Dec 31. PMID: 33381863.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?